Puma Biotechnology Inc (PBYI) Dividend History
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. Cougar further developed abiraterone before the company was sold to Johnson & Johnson in 2009. Auerbach brought many Cougar employees with him after founding Puma in 2010.
Last update 12/03/2023
Dividend Yield Summary
|Date||Amount Per Share||Note|